(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 4.35% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Anika Therapeutics's revenue in 2026 is $120,654,000.On average, 4 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,660,424,592, with the lowest ANIK revenue forecast at $1,583,071,048, and the highest ANIK revenue forecast at $1,722,521,554. On average, 4 Wall Street analysts forecast ANIK's revenue for 2027 to be $1,750,759,612, with the lowest ANIK revenue forecast at $1,665,643,948, and the highest ANIK revenue forecast at $1,819,949,546.
In 2028, ANIK is forecast to generate $1,863,042,697 in revenue, with the lowest revenue forecast at $1,774,447,462 and the highest revenue forecast at $1,934,373,906.